miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

Targeted Oncology - France
doi 10.1007/s11523-017-0478-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Plasma microRNAs as Potential Biomarkers for Non-Small-Cell Lung Cancer

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

The Potential of MiRNAs as Biomarkers and Therapy Targets for Cancer

Journal Of Medicine & Health
2016English

Cetuximab and Biomarkers in Non-Small-Cell Lung Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Non-Small Cell Lung Cancer: Therapeutic and Evolutionary Aspects in Cote D’Ivoire

Advances in Lung Cancer
2018English

Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?

Current Respiratory Care Reports
2013English

Adjuvant Therapy in Non-Small Cell Lung Cancer: Current and Future Directions

Oncologist
Cancer ResearchMedicineOncology
2010English

Hsa-miR-326 Targets CCND1 and Inhibits Non-Small Cell Lung Cancer Development

Oncotarget
Oncology
2016English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy